Market header image

Bulletins

Vous êtes ici

2011-0510 - New Listing - Pivotal Therapeutics Inc. (PVO)

May 18, 2011


The common shares of Pivotal Therapeutics Inc. have been approved for listing on CNSX.  The Company has 68,986,117 common shares outstanding with a public float of approximately 49.6 million shares.

Pivotal is a re-profiling specialty pharmaceutical company that creates novel uses for currently marketed or near market drugs or therapeutics. Pivotal’s first product, VASCAZENTM, is a prescription-only medical food to be used for the clinical dietary management of cardiovascular disease in patients with documented coronary heart disease (CHD), deficient in blood omega-3 fatty acid, Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) levels.

Listing and disclosure documents for Pivotal Therapeutics Inc. will be available in the CNSX Listings Disclosure Hall.

Trading Date: Thursday, May 19, 2011
Symbol: PVO
CUSIP: 72582E 10 4
ISIN: CA 72582E 10 4 3

Applications are being accepted for Market Makers for "PVO ". If you have any questions or require further information please contact Radhika at (416) 572-2000 X 2435 or E-mail: radhika.ramkarran@cnsx.ca



CSE Listing(s):

Advertisement

Publicité

Dernières nouvelles CSE

Évènements à venir

2021-12-09-Nation-Builder-of-the-Year-Award-2021_Website.jpg

2021 Nation Builder of the Year Award

Jeudi, décembre 9, 2021 -
12:00 - 13:00
JM_DigitalBanners_VRIC_Website.jpg

Vancouver Resource Investment Conference (VRIC)

Dimanche, janvier 16, 2022 - 08:30 - Lundi, janvier 17, 2022 - 17:30
Can-Securities-Exchange_PDAC22_web-740x374_Website.jpg

90th Annual PDAC Convention 2022

Lundi, mars 7, 2022 (Jour entier) - Vendredi, mars 11, 2022 (Jour entier)

Advertisement

Publicité